The Effect of SARS-CoV-2 İnfection on Perinatal Outcomes in Hypertensive Disorders of Pregnancy

Nihat Farisoğulları, Ramazan Denızlı, Bedri Sakcak, Atakan Tanaçan, Özgür Kara, Dilek ŞahinRevista 2023 · DOI

Abstract

Physicians should be cautious about the management of hypertensive disorders of pregnancy cases with SARS-CoV-2 positivity. Fetal loss seems to be more common in cases with SARS-CoV-2 positivity and severe COVID-19 seems to be associated with higher rates of maternal complications. Close follow-up for fetal wellbeing and active management of severe cases in terms of maternal complications seem to be favorable.

Introduction

Hypertensive disorders of pregnancy (HDP)—including preeclampsia and gestational hypertension—affect 6% to 8% of pregnancies and are leading causes of maternal and fetal morbidity. HDP and COVID-19 share a common pathological playground: the vascular endothelium. Both conditions involve inflammation, endothelial dysfunction, and the ACE-2 receptor. This retrospective study investigates the clinical "double hit" of SARS-CoV-2 infection and HDP, seeking to determine if the viral infection acts as a catalyst for worse outcomes in this high-risk population.

Methods

The study analyzed data from 108 patients at Ankara City Hospital, Turkey, between April 2020 and April 2022. The study group consisted of 55 pregnant women with HDP who tested positive for SARS-CoV-2 via PCR, while the control group included 53 HDP patients who tested negative, matched for demographic characteristics. The COVID-positive group was further stratified into "severe" (n=11) and "non-severe" (n=44) subgroups based on respiratory symptoms and oxygen saturation. Researchers compared maternal demographics, laboratory markers, and perinatal outcomes using standard statistical methods.

Results

The most striking finding was the significant disparity in fetal mortality. Intrauterine fetal death (IFD) occurred in 10.9% (6/55) of the COVID-positive group, compared to 0% in the control group (p = 0.027). Notably, five of these six fetal deaths occurred in the "non-severe" COVID-19 subgroup, suggesting that even mild viral infection can be catastrophic when superimposed on hypertensive disorders.

Table 2: Perinatal and maternal outcomes comparing SARS-CoV-2 positive and negative groups.

Laboratory markers also showed differences; ALT levels were significantly higher in the COVID-positive group (p = 0.023), while the control group exhibited higher baseline blood pressures and creatinine levels at admission.

Discussion

The shared pathophysiology of HDP and SARS-CoV-2, involving the ACE-2 receptor and endothelial damage, may trigger sudden hypertensive attacks or placental vascular malperfusion. Pathological evaluation of placentas in fetal loss cases revealed infarction, intervillous hemorrhage, and focal necrosis, pointing toward a direct vascular impact on the fetal-maternal interface.

Furthermore, the severity of COVID-19 significantly influenced maternal outcomes. Patients with severe COVID-19 experienced significantly longer hospital stays and higher rates of intensive care unit (ICU) admission compared to non-severe cases.

Table 4: Perinatal and maternal outcomes in non-severe and severe SARS-CoV-2 subgroups.

Conclusion

SARS-CoV-2 infection significantly worsens outcomes for pregnant women with hypertensive disorders, primarily through a stark increase in fetal loss and increased maternal morbidity in severe cases. These findings necessitate aggressive monitoring of fetal wellbeing following a positive COVID-19 diagnosis in HDP patients. While limited by a small sample size and retrospective design, this study highlights a critical clinical synergy. Future research should focus on the impact of vaccination status on these vascular risks.

Summary updated

Abstract

Physicians should be cautious about the management of hypertensive disorders of pregnancy cases with SARS-CoV-2 positivity. Fetal loss seems to be more common in cases with SARS-CoV-2 positivity and severe COVID-19 seems to be associated with higher rates of maternal complications. Close follow-up for fetal wellbeing and active management of severe cases in terms of maternal complications seem to be favorable.
BibTeX
@inproceedings{farisogullar2023effect,
  author = {Nihat Farisoğulları and Ramazan Denızlı and Bedri Sakcak and Atakan Tanaçan and Özgür Kara and Dilek Şahin},
  title = {{The Effect of SARS-CoV-2 İnfection on Perinatal Outcomes in Hypertensive Disorders of Pregnancy}},
  booktitle = {Revista},
  year = {2023},
  doi = {10.1055/s-0043-1772184},
}
Figure